Ropivacaine

Generic Name
Ropivacaine
Brand Names
Naropin
Drug Type
Small Molecule
Chemical Formula
C17H26N2O
CAS Number
84057-95-4
Unique Ingredient Identifier
7IO5LYA57N
Background

Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.

Indication

Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.

Associated Conditions
Acute Pain, Postoperative pain
Associated Therapies
Surgical anesthesia therapy

Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2012-04-10
Last Posted Date
2015-08-24
Lead Sponsor
Nationwide Children's Hospital
Target Recruit Count
3
Registration Number
NCT01575028
Locations
🇺🇸

Nationwide Children's Hospital, Columbus, Ohio, United States

Effect of Adductor-Canal-Blockade on High Pain Responders After Total Knee Arthroplasty

First Posted Date
2012-03-09
Last Posted Date
2013-01-08
Lead Sponsor
University Hospital, Gentofte, Copenhagen
Target Recruit Count
50
Registration Number
NCT01549704
Locations
🇩🇰

Gentofte Hospital, Copenhagen, Denmark

Local Infiltration Versus Block Against Pains After High Tibial Osteotomy

Phase 4
Completed
Conditions
Interventions
First Posted Date
2012-02-23
Last Posted Date
2016-01-22
Lead Sponsor
Northern Orthopaedic Division, Denmark
Target Recruit Count
60
Registration Number
NCT01537146
Locations
🇩🇰

Northern Orthopaedic Division, Clinik Farsoe, Aalborg University Hospital, Farsoe, Northern Jutland, Denmark

Duration of Leg Nerve Blocks With Dexamethasone Added to Local Anesthetic

First Posted Date
2012-01-18
Last Posted Date
2013-09-12
Lead Sponsor
University of New Mexico
Registration Number
NCT01511211
Locations
🇺🇸

University of New Mexico Hospital, Albuquerque, New Mexico, United States

Minimum Effective Volume of Ropivacaine 7.5 mg/ml for the Lateral and Sagittal Infraclavicular Brachial Plexus Block

Phase 4
Completed
Conditions
First Posted Date
2011-12-16
Last Posted Date
2012-09-11
Lead Sponsor
University Hospital of North Norway
Target Recruit Count
25
Registration Number
NCT01493986
Locations
🇳🇴

University Hospital of North Norway, Tromsø, Troms, Norway

Analgesia After Total Knee Replacement Surgery

First Posted Date
2011-12-09
Last Posted Date
2015-06-08
Lead Sponsor
St. Antonius Hospital
Target Recruit Count
81
Registration Number
NCT01489631
Locations
🇳🇱

St. Antonius Hospital, Nieuwegein, Netherlands

Selective Block of the Axillary Nerve in Postoperative Pain Management

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-11-02
Last Posted Date
2015-03-20
Lead Sponsor
Hillerod Hospital, Denmark
Target Recruit Count
60
Registration Number
NCT01463865
Locations
🇩🇰

Aleris-Hamlet Hospital, Frederiksberg, Denmark

Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery

First Posted Date
2011-10-10
Last Posted Date
2016-06-17
Lead Sponsor
Mayo Clinic
Target Recruit Count
130
Registration Number
NCT01450007
Locations
🇺🇸

Mayo Clinic in Arizona, Phoenix, Arizona, United States

Formulations of Liposomal Local Anesthetics

First Posted Date
2011-03-03
Last Posted Date
2011-03-03
Lead Sponsor
University of Campinas, Brazil
Target Recruit Count
40
Registration Number
NCT01307969
Locations
🇧🇷

Piracicaba Dental School, Piracicaba, São Paulo, Brazil

© Copyright 2024. All Rights Reserved by MedPath